Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson’s disease, in healthy volunteers
Storage and Handling Peptides are sensitive molecules that can degrade if not stored and handled properly
Read our in-depth KLOW Blend research profile For In Vitro Research Use Only Not for Human or Veterinary Use Description Additional information For In Vitro Research Use Only Not for Human or Veterinary Use Total Mass 80 mg (4 Components) Pathways 4 Complementary Mechanisms Chemical & Physical Specifications About KLOW Blend (Multi-Peptide Research Complex) KLOW Blend is a pre-formulated multi-component research preparation combining four peptidesGHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg)in a single lyophilized vial totaling 80mg
A big research project discovered that people who had tinnitus became 1.5 times more susceptible to developing Alzheimer's disease and Parkinson's disease during the following decade than those who did not have tinnitus
The incidence of T2DM in the younger group surged by 120%, highlighting a troubling trend in youth diabetes rates
US$ 26.32
US$ 26.55
US$ 23.68
US$ 23.49
US$ 25.54
US$ 21.79
